Management of Seizures and Status Epilepticus S. Andrew Josephson - - PDF document

management of seizures and status epilepticus
SMART_READER_LITE
LIVE PREVIEW

Management of Seizures and Status Epilepticus S. Andrew Josephson - - PDF document

10/26/2015 Management of Seizures and Status Epilepticus S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Senior Executive Vice Chair, Department of Neurology Director,


slide-1
SLIDE 1

10/26/2015 1

Management of Seizures and Status Epilepticus

  • S. Andrew Josephson MD

Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Senior Executive Vice Chair, Department of Neurology Director, Neurohospitalist Program Medical Director, Inpatient Neurology University of California, San Francisco

The speaker has no disclosures

Emergent ICP Management

  • Step 1: Head of bed to 30 degrees
  • Step 2: Hyperventilation

– Cerebral vasoconstriction with decreased PaCO2 – Onset rapid – Lasts only 1-2 hours as buffering occurs

  • Step 3: Mannitol 1 gram/kg IV (50-100g)

– Removes brain water – Tolerance develops, must follow serum osms

  • Step 4: Barbiturates (bolus then infusion)
  • Consider ventriculostomy if indicated!
slide-2
SLIDE 2

10/26/2015 2

Emergent CPP Management

Cerebral Perfusion Pressure (CPP) CPP = MAP - ICP

Case #2

  • A 67F is hospitalized with a community-acquired
  • pneumonia. On Day#3 she is feeling much better

awaiting discharge when her nurse finds her unresponsive with rhythmic shaking of all limbs.

  • PMHx: COPD
  • Meds: Ceftriaxone, NKDA
  • SH: 100pk yr hx tobacco, no hx EtOH
  • FH: No neurologic disease
slide-3
SLIDE 3

10/26/2015 3

Case #2

  • You are called to the bedside and after 3

minutes, these movements have not

  • stopped. Options for your next course of

action are….

  • A. Continue to wait for the spell to subside
  • B. Administer IV Diazepam
  • C. Administer IV Lorazepam
  • D. Administer IV Fosphenytoin

Case #2

  • Following Lorazepam 2mg IV x 3 (2

minutes apart), the patient is still having these movements (now 7 minutes). What is your next course of action?

slide-4
SLIDE 4

10/26/2015 4

Status Epilepticus

  • Changing definition and time window
  • Incidence: 100,000 to 150,000 per year nationally
  • Contributes to 55,000 deaths per year nationally
  • 12 to 30 percent of epilepsy first presents as status
  • Generalized convulsive status most dangerous

Status Epilepticus Algorithm: Real World

  • 1. Lorazepam 2mg IV q2 minutes up to 6-

8mg or Midazolam 10mg IM*

  • 2. Fosphenytoin 18-20mg/kg (Dilantin

Equivalents) IV

  • 2a. Fosphenytoin additional 10mg/kg or

Phenobarbital

  • 3. General Anesthesia with continuous EEG
  • a. IV Midazolam gtt
  • b. IV Propofol gtt
slide-5
SLIDE 5

10/26/2015 5

Rossetti AO Lancet Neurol, 2011

IM Midazolam: RAMPART

  • Out of hospital non-inferiority trial

– 4 mg lorazepam IV vs. 10 mg midazolam IM (the latter using a novel autoinjector)

  • Primary outcome: absence of sz at time of

ED arrival without the need for rescue therapy

Silbergleit R, et al. N Engl J Med, 2012

slide-6
SLIDE 6

10/26/2015 6

Status Epilepticus: New Advances

  • IV formulations of Depakote (Depacon) and

Levetiracetam (Keppra)

– Ongoing randomized trial

  • Decreased incidence in epileptics with

prescribed “Status Rescue Meds”

– Important to remember at time of discharge from the hospital

Seizure Management: Once the Spell Stops

  • Key Question:

1st seizure or known epilepsy

slide-7
SLIDE 7

10/26/2015 7

Seizure Management: First Seizure

  • Careful history of the spell: before

(including recent events), during, after

  • Determine all meds patient is on
  • Careful neuro exam looking for focal signs

– Focal exam= Partial seizure= Focal lesion

Seizure Management: First Seizure

  • Work-up for provokers

– Head trauma? – Utox, EtOH history and possible level – CBC, Lytes, Ca/Mg/Phos, BUN/Cr, LFTs – CT (usually with contrast) – Very low threshold to LP

  • Needs outpatient work up including: EEG,

MRI, and neurologic consultation

slide-8
SLIDE 8

10/26/2015 8

Seizure Management: Known Epilepsy

  • 1. Non-compliance

– Determine AEDs including doses – Send levels of AEDs if possible – Med-Med interactions

  • 2. Infection

– CXR, urine, blood cx, consider LP

  • Best to curbside primary neurologist regarding any

medication changes to current regimen

Quick Cases: Seizures in ED

45 yo male with recent +PPD won’t stop seizing Order IV B6 to treat pyridoxine-deficient seizures secondary to INH 55 yo female on bone marrow transplant service given amphotericin Check Ca/Mg/Phos and replete low Mg Most new seizures over 40 in urban areas EtOH withdrawal seizures: treatment with benzos and NOT AEDs

slide-9
SLIDE 9

10/26/2015 9

Talk Like a Neurologist: Seizure Types

  • 1. Partial Seizures
  • Simple Partial
  • Complex Partial
  • 2. Generalized Seizures
  • Clonic
  • Tonic
  • Tonic-Clonic
  • Absence
  • Myoclonic
  • Atonic

Video Examples

slide-10
SLIDE 10

10/26/2015 10

Non-Epileptic Spells

  • Diagnosis of Exclusion

– Comprise 20% of epilepsy clinic new patients

  • Only established via Video EEG Telemetry

– Complex partial seizure similar by history

  • More common in those with true epilepsy
  • Patients not “faking”
  • Comprehensive approach with

neuropsychology is a must for treatment

– Recent data supports CBT

Non-Epileptic Spells: Clues to Diagnosis

  • Seizures refractory to multiple AEDs
  • Clinical clues not 100% but useful

– 1. Ictal eye closure – 2. Bilateral movements with preserved consciousness – 3. Pelvic thrusting

slide-11
SLIDE 11

10/26/2015 11

Non-Epileptic Spells

Long term outcome: 164 patients with diagnosed non-epileptic spells followed for 1-10 years

– 71.2% still had spells and 56.4% on disability2

Neurology Sept 2003;61: 714-5 Ann Neurol 2003;53:305-11

Seizure Management in the ED: Should We Treat a First Seizure?

  • “Provoked”: Do not treat
  • Data for recurrence if 1st seizure not provoked

– 26-71% 2 year recurrence – Many models: Non-evidenced based rule of thumb involving neuro exam, EEG and MRI

  • Sudden unexpected death in epilepsy (SUDEP)

(1.21/1000 patient years)

slide-12
SLIDE 12

10/26/2015 12

Can they Drive?

  • If the patient has had an seizure with AMS,

should not be driving a car for 3-6 months

– Unless provoked and that factor has been removed

  • State reporting laws to the DMV differ

– California law (5 other states)

  • Includes syncope!

Case #3

  • An 86 year-old woman with a history of stroke

presents with 2 days of confusion.

  • General physical exam is normal. On neurologic

examination the patient is somnolent and will not arouse to voice. The rest of the neurologic examination is normal except for fine nystagmus in all directions of gaze.

  • Labs: Lytes, CBC, BUN/Cr, LFTs, Utox all nl
  • CT head negative, CXR negative, U/A negative
slide-13
SLIDE 13

10/26/2015 13

What is the next test you would like to order?

  • A. MRI Brain
  • B. LP
  • C. Blood Cultures
  • D. Urinary Porphyrins
  • E. EEG

Seizure-Related AMS

  • Non-convulsive status epilepticus
  • Post-ictal states that may be prolonged

– Coma – Focal Neurologic Deficits (Todd’s phenomena) – Psychosis – Confusion

  • Can only diagnose with EEG
slide-14
SLIDE 14

10/26/2015 14

This is uncommon…right?

  • Study of 1048 patients admitted to the

hospital floor (not ICU) who underwent EEG monitoring for “altered mental status”

  • r “unexplained spells”
  • Seizures in 7.4%
  • Epileptiform discharges in 18.5%
  • How much of this are we missing???

Betjemann JP Mayo Clin Proc 88:326,2013

A healthy 36M with a hx of seizures on Dilantin 300mg/d comes to your office for routine care. He has had no seizures and has a normal exam. A phenyotin level is 36 (10-20). Your next course of action is…

  • A. Check an albumin level and renal function
  • B. Reduce the Dilantin dose
  • C. Make no changes to the Dilantin dose
  • D. Switch to carbamazepine
  • E. Admit to the hospital for dialysis
slide-15
SLIDE 15

10/26/2015 15

Monotherapy for Seizures

  • 70 percent of epilepsy can be managed with

monotherapy, most on first drug tried

  • Concept of Maximal Tolerated Dose (MTD)
  • Rarely check levels

– Assess compliance – Steady state level – Not practically available with newer AEDs

N Engl J Med. 2000 Feb 3;342(5):314-9

New Drugs: Clinical Pearls

  • IV formulations: VPA, DPH, PHB, LVT
  • Levels to Monitor: VPA, DPH, CBZ, PHB
  • Lamotrigine (Lamictal)

– Rash (1/1000) progressing to Stevens-Johnson

  • Levetiracetam (Keppra)

– No drug interactions (useful on HAART), but NOT a first line agent

  • Topiramate (Topamax)

– Well tolerated? weight loss and cognitive side effects

slide-16
SLIDE 16

10/26/2015 16

New Drugs: Clinical Pearls

  • Oxcarbazepine (Trileptal)

– Tegretol pro-drug, hyponatremia

  • Felbamate (Felbatol)

– Aplastic Anemia with required registry

  • Pregabalin (Lyrica)

– Useful for neuropathic pain

  • Gabapentin (Neurontin)

– Not a great AED

Women and Epilepsy

  • Some medications less tolerated by women

Example: Depakote causes hirsutism, weight gain and often coarsening of facial features so relatively contraindicated in growing young women and girls

  • Catamenial epilepsy

– Brief AED pulses – Other agents: Diamox – Menstruation control

slide-17
SLIDE 17

10/26/2015 17

Women and Epilepsy: OCPs

  • Pregnancy must be planned due to neural

tube defect risk on AEDs

  • Many AEDs decrease levels of OCPs and

therefore higher OCP dosing (40mcg estrogen) recommended for efficacy

– Always recommend double contraception

  • AEDs can lead to reproductive dysfunction

and PCOS, especially with VPA and CBZ

Which of the following drugs is not associated with teratogenic effects?

  • A. Valproic Acid
  • B. Phenytoin
  • C. Lamotrigine
  • D. Carbamazepine
  • E. Phenobarbital
slide-18
SLIDE 18

10/26/2015 18

Women and Epilepsy: Pregnancy

  • Folic acid to decrease neural tube defects (NTDs)

in women on AEDs

– NTD risk doubles from 2-3% to 4-6% – Folate deficiency implicated in NTDs – 1-4mg/day regardless of AED PRIOR to conception – Prenatal diagnostic ultrasound

  • “AED syndrome”

– Microcephaly, low set ears, short neck, transverse palmar crease, skeletal abnormalities

Other Epilepsy Treatments

  • Vagal Nerve Stimulator (VNS)
  • Diet
slide-19
SLIDE 19

10/26/2015 19

Other Epilepsy Treatments

  • Epilepsy Surgery

– Temporal lobectomy, focal resections, callosotomy, functional hemispherectomy – Randomized trial successful but underpowered

  • Refer to tertiary center for consideration of

surgery any patient who remains uncontrolled despite adequate doses of AEDs

JAMA 2012 Mar 7;307(9):922-30.